Dashboard
Manage Tickers

AVTX Avalo Therapeutics, Inc.

Nasdaq avalotx.com


$ 14.12 $ 0.09 (0.61 %)    

Wednesday, 15-Oct-2025 10:48:19 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 606.07 $ 2.17 (0.36 %)
DIA $ 465.73 $ 1.06 (0.23 %)
SPY $ 668.93 $ 2.13 (0.32 %)
TLT $ 91.18 $ 0.22 (0.24 %)
GLD $ 386.15 $ 0.12 (0.03 %)
$ 13.99
$ 13.99
$ 14.12 x 59
$ 14.20 x 67
$ 13.70 - $ 14.11
$ 3.39 - $ 16.00
169,313
na
184M
$ 0.87
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-12-2025 03-31-2025 10-Q
3 03-20-2025 12-31-2024 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-12-2024 06-30-2024 10-Q
6 05-13-2024 03-31-2024 10-Q
7 03-29-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 03-29-2023 12-31-2022 10-K
12 11-07-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 03-02-2022 12-31-2021 10-K
16 11-09-2021 09-30-2021 10-Q
17 08-02-2021 06-30-2021 10-Q
18 05-13-2021 03-31-2021 10-Q
19 03-08-2021 12-31-2020 10-K
20 11-09-2020 09-30-2020 10-Q
21 08-06-2020 06-30-2020 10-Q
22 05-07-2020 03-31-2020 10-Q
23 03-11-2020 12-31-2019 10-K
24 11-14-2019 09-30-2019 10-Q
25 08-08-2019 06-30-2019 10-Q
26 05-09-2019 03-31-2019 10-Q
27 03-18-2019 12-31-2018 10-K
28 11-13-2018 09-30-2018 10-Q
29 08-09-2018 06-30-2018 10-Q
30 05-11-2018 03-31-2018 10-Q
31 04-02-2018 12-31-2017 10-K
32 11-07-2017 09-30-2017 10-Q
33 08-14-2017 06-30-2017 10-Q
34 05-09-2017 03-31-2017 10-Q
35 03-14-2017 12-31-2016 10-K
36 11-08-2016 09-30-2016 10-Q
37 08-15-2016 06-30-2016 10-Q
38 05-16-2016 03-31-2016 10-Q
39 03-23-2016 12-31-2015 10-K
40 11-13-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
09/29/2025 12:09:33

Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday's pre-market session. The ...

why-merus-shares-are-trading-higher-by-38-here-are-20-stocks-moving-premarket
Why Merus Shares Are Trading Higher By 38%...
09/29/2025 09:07:53

Shares of Merus NV (NASDAQ: MRUS) rose sharply in today's pre-market trading. Genmab announced plans to acquire Merus fo...

hc-wainwright--co-maintains-buy-on-avalo-therapeutics-raises-price-target-to-25
HC Wainwright & Co. Maintains Buy on Avalo...
09/17/2025 15:51:42

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Avalo Therapeutics (NASDAQ:AVTX) with a Buy and raises the pric...

cantor-fitzgerald-initiates-coverage-on-avalo-therapeutics-with-overweight-rating
Cantor Fitzgerald Initiates Coverage On Av...
08/15/2025 12:55:16

Cantor Fitzgerald analyst Prakhar Agrawal initiates coverage on Avalo Therapeutics (NASDAQ:AVTX) with a Overweight rating.

avalo-therapeutics-q2-eps-192-misses-142-estimate-cash-cash-equivalents-and-short-term-investments-were-1133m-as-of-june-30
Avalo Therapeutics Q2 EPS $(1.92) Misses $...
08/07/2025 11:17:40

Avalo Therapeutics (NASDAQ:AVTX) reported quarterly losses of $(1.92) per share which missed the analyst consensus estimate of ...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
08/01/2025 12:07:59

hc-wainwright--co-assumes-avalo-therapeutics-at-buy-announces-price-target-of-15
HC Wainwright & Co. Assumes Avalo Therapeu...
06/02/2025 10:43:19

HC Wainwright & Co. analyst Mitchell Kapoor assumes Avalo Therapeutics (NASDAQ:AVTX) with a Buy rating and announces Pri...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
05/14/2025 21:05:46

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
05/12/2025 12:08:42

avalo-therapeutics-q1-2025-eps-125-beats-139-estimate-cash-on-hand-of-approximately-125-as-of-march-31-2025-expected-to-provide-runway-into-2027-with-optionality-to-extend-into-2028
Avalo Therapeutics Q1 2025 EPS $(1.25) Bea...
05/12/2025 11:11:01

avalo-therapeutics-represents-an-attractive-pure-play-analyst-initiates-coverage-with-over-300-stock-upside
Avalo Therapeutics 'Represents An Attracti...
03/25/2025 19:20:44

Avalo Therapeutics' AVTX-009 is advancing in hidradenitis suppurativa, with Phase 2 data expected in 2026. Stifel initiates...

jefferies-initiates-coverage-on-avalo-therapeutics-with-buy-rating-announces-price-target-of-23
Jefferies Initiates Coverage On Avalo Ther...
03/25/2025 12:14:15

Jefferies analyst Kambiz Yazdi initiates coverage on Avalo Therapeutics (NASDAQ:AVTX) with a Buy rating and announces Price ...

stifel-initiates-coverage-on-avalo-therapeutics-with-buy-rating-announces-price-target-of-36
Stifel Initiates Coverage On Avalo Therape...
03/25/2025 11:00:05

Stifel analyst Alex Thompson initiates coverage on Avalo Therapeutics (NASDAQ:AVTX) with a Buy rating and announces Price Ta...

hc-wainwright--co-reiterates-neutral-on-avalo-therapeuticsto-neutral
HC Wainwright & Co. Reiterates Neutral on ...
03/20/2025 15:55:21

HC Wainwright & Co. analyst Edward White reiterates Avalo Therapeutics (NASDAQ:AVTX) from Neutral to Neutral.

this-costar-group-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-friday
This CoStar Group Analyst Begins Coverage ...
02/28/2025 19:33:24

piper-sandler-initiates-coverage-on-avalo-therapeutics-with-overweight-rating-announces-price-target-of-48
Piper Sandler Initiates Coverage On Avalo ...
02/28/2025 13:23:41

Piper Sandler analyst Yasmeen Rahimi initiates coverage on Avalo Therapeutics (NASDAQ:AVTX) with a Overweight rating and ann...

btig-initiates-coverage-on-avalo-therapeutics-with-buy-rating-announces-price-target-of-40
BTIG Initiates Coverage On Avalo Therapeut...
12/19/2024 17:47:31

BTIG analyst Julian Harrison initiates coverage on Avalo Therapeutics (NASDAQ:AVTX) with a Buy rating and announces Price Ta...

lucid-capital-markets-initiates-coverage-on-avalo-therapeutics-with-buy-rating-announces-price-target-of-24
LUCID CAPITAL MARKETS Initiates Coverage O...
12/17/2024 15:45:29

LUCID CAPITAL MARKETS analyst Dev Prasad initiates coverage on Avalo Therapeutics (NASDAQ:AVTX) with a Buy rating and annou...

avalo-therapeutics-has-received-694m-in-gross-proceeds-from-the-full-exercise-of-the-warrants-issued-in-march-2024-private-placement
Avalo Therapeutics Has Received $69.4M In ...
11/12/2024 12:49:45

Proceeds from the full exercise of warrants issued in the first quarter of 2024 private placement bring the total gross proceed...

avalo-therapeutics-q3-2024-gaap-eps-283-misses-119-estimate-cash-position-of-approximately-82m-with-subsequent-receipt-of-approximately-58m-of-warrant-exercise-proceeds-in-4q-2024-provides-expected-runway-into-at-least-2027
Avalo Therapeutics Q3 2024 GAAP EPS $(2.83...
11/07/2024 12:33:35

Avalo Therapeutics (NASDAQ:AVTX) reported quarterly losses of $(2.83) per share which missed the analyst consensus estimate of ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION